Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
6.89 Up 0.05(0.73%) Jul 1, 4:00PM EDT
Add to Portfolio
Prev Close:6.84
Open:6.87
Bid:5.45 x 500
Ask:7.46 x 600
1y Target Est:8.60
Beta:1.42
Next Earnings Date: 3-Aug-15SPPI Earnings announcement
Day's Range:6.72 - 7.05
52wk Range:5.45 - 9.27
Volume:1,097,455
Avg Vol (3m):996,833
Market Cap:461.60M
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIUp 0.73%461.60M
BIIBUp 0.36%95.36B
RHHBYUp 0.20%N/A
TEVAUp 3.13%51.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.47
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-15) :-1.05
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback